Department of Pediatric Nephrology and Center for Cardiovascular Research, Charité - University Medicine, Berlin, Germany.
Division of Pediatric Nephrology, Center for Pediatric and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.
Sci Rep. 2019 Jul 16;9(1):10316. doi: 10.1038/s41598-019-46805-5.
Chronic kidney disease (CKD) greatly increases the risk for cardiovascular disease (CVD). However, molecular mechanisms underlying CKD-induced arterial remodeling are largely unknown. We performed a systematic analysis of arterial biopsies from children with stage 5 predialysis CKD participating in the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4 C) study. For comparison, we studied biopsies from children without CKD, coronary bypass vessels from adults with atherosclerotic coronary heart disease without CKD and aortic sections of subtotally nephrectomized rats. In pediatric CKD patients, gene expression was correlated to the cardiovascular phenotype assessed by surrogate end-points. The arterial calcium content correlated with the intima-media thickness (IMT) of biopsied vessels from pediatric CKD patients, was markedly increased compared to biopsies from children without CKD and comparable to adult coronary bypass patients. Significant transcriptional changes included ECM components, pro-calcifying factors, and physiological calcification inhibitors; most were highly accordant with changes observed in adults with atherosclerosis and in uremic rats. Individual gene expression levels were significantly associated with the left ventricular mass index and carotid intima media thickness. Thus, inflammatory processes (TNF, IL-10), calcification inhibitors (CA2), the Wnt-pathway (FGF-2) and foremost, ECM components (HMGA1, VNN1, VCAN), impact pathobiological responses in arteries from children with CKD.
慢性肾脏病(CKD)大大增加了心血管疾病(CVD)的风险。然而,CKD 引起的动脉重塑的分子机制在很大程度上尚不清楚。我们对参与心血管合并症在儿童慢性肾脏病(4C)研究的 5 期未透析 CKD 儿童的动脉活检进行了系统分析。为了进行比较,我们研究了无 CKD 的儿童的活检、无 CKD 的动脉粥样硬化性冠心病成人的冠状动脉旁路血管以及大部分肾切除大鼠的主动脉切片。在儿科 CKD 患者中,基因表达与通过替代终点评估的心血管表型相关。动脉钙含量与儿科 CKD 患者活检血管的内膜中层厚度(IMT)相关,与无 CKD 的儿童的活检相比显著增加,与成人冠状动脉旁路患者相当。显著的转录变化包括 ECM 成分、促钙化因子和生理性钙化抑制剂;其中大多数与动脉粥样硬化和尿毒症大鼠中观察到的变化高度一致。个体基因表达水平与左心室质量指数和颈动脉内膜中层厚度显著相关。因此,炎症过程(TNF、IL-10)、钙化抑制剂(CA2)、Wnt 通路(FGF-2)以及最重要的 ECM 成分(HMGA1、VNN1、VCAN),影响了 CKD 儿童动脉的病理生物学反应。